Song, Chengyang
Shang, Fangjian
Tu, Wei
Liu, Xiaodan
Funding for this research was provided by:
The Cultivating Project of the Fourth Affiliated Hospital of China Medical University (No. F00054)
Article History
Received: 28 May 2022
Accepted: 20 March 2023
First Online: 31 March 2023
Declarations
:
: Due to the retrospective study design, the ethical review board of the Fourth Affiliated Hospital of China Medical University approved a waiver of written informed consent for the use of breast tumour specimens (China Medical University, Shenyang, China, application number EC-2021-KS-075). All procedures for the breast cancer validation cohort were performed in accordance with the Declaration of Helsinki and approved by the Medical Faculty Research Ethics Committee (China Medical University, Shenyang, China, application number EC-2021-KS-075).
: Not applicable.
: The authors declare no competing interests.